Correlation Between Candel Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Tempest Therapeutics.
Diversification Opportunities for Candel Therapeutics and Tempest Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Candel and Tempest is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 0.9 times more return on investment than Tempest Therapeutics. However, Candel Therapeutics is 1.11 times less risky than Tempest Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 627.00 in Candel Therapeutics on August 28, 2024 and sell it today you would lose (143.00) from holding Candel Therapeutics or give up 22.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| Candel Therapeutics |
| Tempest Therapeutics |
Candel Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite Candel Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |